ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,091,000 | +513.2% | 25,250 | +389.9% | 0.19% | +551.7% |
| Q1 2021 | $341,000 | -67.1% | 5,154 | -61.9% | 0.03% | -65.5% |
| Q4 2020 | $1,037,000 | -43.8% | 13,516 | -68.5% | 0.08% | -47.8% |
| Q3 2020 | $1,845,000 | +22.4% | 42,864 | +22.8% | 0.16% | +3.9% |
| Q2 2020 | $1,507,000 | -65.2% | 34,893 | -76.8% | 0.16% | -67.2% |
| Q1 2020 | $4,327,000 | +23.3% | 150,401 | +171.9% | 0.47% | +345.3% |
| Q4 2019 | $3,508,000 | +15.6% | 55,315 | -51.7% | 0.11% | -10.2% |
| Q2 2019 | $3,034,000 | +68.7% | 114,504 | +16.8% | 0.12% | +13.5% |
| Q1 2019 | $1,798,000 | +785.7% | 98,005 | +77.2% | 0.10% | +3366.7% |
| Q4 2017 | $203,000 | +866.7% | 55,300 | +385.1% | 0.00% | – |
| Q1 2017 | $21,000 | -80.2% | 11,400 | -83.5% | 0.00% | -100.0% |
| Q4 2016 | $106,000 | -10.2% | 68,900 | +328.0% | 0.00% | -25.0% |
| Q3 2016 | $118,000 | -10.6% | 16,100 | -35.3% | 0.00% | -33.3% |
| Q2 2016 | $132,000 | – | 24,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |